Corticosteroid Injection for Hoffa's Syndrome

This trial explores the effectiveness of a corticosteroid injection for treating knee pain from Hoffa's Fat Pad Impingement in young female athletes. Participants will receive either a corticosteroid injection (Methylprednisolone Acetate) or a saline injection, both combined with physical therapy, to determine which approach better alleviates pain and improves activity levels. Ideal candidates are girls aged 12-18 who play organized sports and continue to experience knee pain despite completing a physical therapy regimen. As a Phase 4 trial, this study involves an FDA-approved treatment and aims to understand its benefits for more patients.

The trial information does not specify whether you need to stop taking your current medications. However, you cannot receive other knee injections during the study period.

Research has shown that corticosteroid injections, like the one under study, are generally safe and well-tolerated. Studies have found that these injections can reduce knee pain and swelling without causing major side effects. Most patients experience only mild discomfort during the injection itself.

The specific corticosteroid used in this study, methylprednisolone acetate, has already received FDA approval for other uses, indicating its safety for people. In studies with patients who have knee osteoarthritis, these injections did not cause serious side effects.

Unlike standard treatments for Hoffa's Syndrome, which typically involve physical therapy and non-steroidal anti-inflammatory drugs (NSAIDs), the corticosteroid injection being studied offers a targeted approach. Researchers are excited because this treatment uses methylprednisolone acetate, a potent anti-inflammatory steroid, and it's delivered directly into the affected area using ultrasound guidance. This precise delivery method can potentially reduce inflammation more effectively and provide quicker symptom relief compared to traditional systemic treatments.

Research has shown that corticosteroid injections, which participants in this trial may receive, reduce knee pain more effectively than a placebo. For example, a review found that these injections offer short-term pain relief compared to a saltwater injection. Specifically, injections into the infrapatellar fat pad (a small cushion of fat under the kneecap) demonstrated significant pain relief and improved knee function after six months. However, some studies suggest that the improvements might not be dramatic for everyone, especially those with knee osteoarthritis. Overall, evidence supports that corticosteroid injections effectively reduce pain for people with issues related to the infrapatellar fat pad, such as Hoffa’s Syndrome.¹²³⁴⁶